Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest

Oncogene

Volumn 31, Issue 19, 2012, Pages 2450-2460

  Russell, P ^a   Hennessy, B T ^b   Li, J ^b   Carey, M S ^b   Bast, R C ^b   Freeman, T ^c   Venkitaraman, A R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

anti mitotic drugs; cancer therapy; cyclin G1; mitotic checkpoint

Indexed keywords

BUB1 RELATED PROTEIN; CYCLIN G1; PACLITAXEL; TAXANE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE CHECKPOINT; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN TISSUE; M PHASE CELL CYCLE CHECKPOINT; MITOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA INTERFERENCE;

ANTIMITOTIC AGENTS; CELL LINE, TUMOR; CYCLIN G1; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; M PHASE CELL CYCLE CHECKPOINTS; MITOSIS; PACLITAXEL; TAXOIDS;

EID: 84861343096     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.431     Document Type: Article

References (31)

1. Abkevich V, Iliev D, Timms KM, Tran T, Skolnick M, Lanchbury JS et al. (2010). Computational method for estimating DNA copy numbers in normal samples, cancer cell lines, and solid tumors using array comparative genomic hybridization. J Biomed Biotechnol 2010: pii 386870.
2. Bates S, Rowan S, Vousden KH. (1996). Characterisation of human cyclin G1 and G2: DNA damage inducible genes. Oncogene 13: 1103-1109. (Pubitemid 26329098)
3. Brito DA, Rieder CL. (2006). Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr Biol 16: 1194-1200. (Pubitemid 43867292)
4. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP et al. (1998). Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501. (Pubitemid 28538613)
5. Daniels MJ, Wang Y, Lee M, Venkitaraman AR. (2004). Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2. Science 306: 876-879. (Pubitemid 39446997)
6. Ditchfield C, Johnson VL, Tighe A, Ellston R, Haworth C, Johnson T et al. (2003). Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J Cell Biol 161: 267-280. (Pubitemid 36529846)
7. Gascoigne KE, Taylor SS. (2008). Cancer cells display profound intraand interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 14: 111-122.
8. Gascoigne KE, Taylor SS. (2009). How do anti-mitotic drugs kill cancer cells? J Cell Sci 122: 2579-2585.
9. Hennessy BT, Coleman RL, Markman M. (2009). Ovarian cancer. Lancet 374: 1371-1382.
10. Huang HC, Mitchison TJ, Shi J. (2010). Stochastic competition between mechanistically independent slippage and death pathways determines cell fate during mitotic arrest. PLoS One 5: e15724.
11. Jordan MA, Wilson L. (2004). Microtubules as a target for anticancer drugs. Nat Rev Cancer 4: 253-265. (Pubitemid 38525281)
12. Kimura SH, Nojima H. (2002). Cyclin G1 associates with MDM2 and regulates accumulation and degradation of p53 protein. Genes Cells 7: 869-880. (Pubitemid 34947089)
13. Lee H, Trainer AH, Friedman LS, Thistlethwaite FC, Evans MJ, Ponder BA et al. (1999). Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2. Mol Cell 4: 1-10. (Pubitemid 29386126)
14. Lew DJ, Burke DJ. (2003). The spindle assembly and spindle position checkpoints. Annu Rev Genet 37: 251-282. (Pubitemid 38041427)
15. Markman M. (2008). Pharmaceutical management of ovarian cancer. Drugs 68: 771-789.
16. Meraldi P, Draviam VM, Sorger PK. (2004). Timing and checkpoints in the regulation of mitotic progression. Dev Cell 7: 45-60. (Pubitemid 39172687)
17. Michalakis J, Georgatos SD, Romanos J, Koutala H, Georgoulias V, Tsiftsis D et al. (2005). Micromolar taxol, with or without hyperthermia, induces mitotic catastrophe and cell necrosis in HeLa cells. Cancer Chemother Pharmacol 56: 615-622. (Pubitemid 41425058)
18. Musacchio A, Salmon ED. (2007). The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 8: 379-393. (Pubitemid 46643240)
19. Okamoto K, Beach D. (1994). Cyclin G is a transcriptional target of the p53 tumor suppressor protein. Embo J 13: 4816-4822. (Pubitemid 24319363)
20. Okamoto K, Li H, Jensen MR, Zhang T, Taya Y, Thorgeirsson SS et al. (2002). Cyclin G recruits PP2A to dephosphorylate Mdm2. Mol Cell 9: 761-771. (Pubitemid 34454888)
21. Okamoto K, Prives C. (1999). A role of cyclin G in the process of apoptosis. Oncogene 18: 4606-4615. (Pubitemid 29405892)
22. Perez R, Wu N, Klipfel AA, Beart Jr RW. (2003). A better cell cycle target for gene therapy of colorectal cancer: cyclin G. J Gastrointest Surg 7: 884-889. (Pubitemid 37338552)
23. Reimer CL, Borras AM, Kurdistani SK, Garreau JR, Chung M, Aaronson SA et al. (1999). Altered regulation of cyclin G in human breast cancer and its specific localization at replication foci in response to DNA damage in p53 ++ cells. J Biol Chem 274: 11022-11029.
24. Rieder CL, Maiato H. (2004). Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev Cell 7: 637-651. (Pubitemid 39462685)
25. Schmittgen TD, Livak KJ. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108. (Pubitemid 351818697)
26. Sena G, Onado C, Cappella P, Montalenti F, Ubezio P. (1999). Measuring the complexity of cell cycle arrest and killing of drugs: kinetics of phase-specific effects induced by taxol. Cytometry 37: 113-124. (Pubitemid 29463480)
27. Shi J, Orth JD, Mitchison T. (2008). Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5. Cancer Res 68: 3269-3276.
28. Sudo T, Nitta M, Saya H, Ueno NT. (2004). Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint. Cancer Research 64: 2502-2508. (Pubitemid 38523906)
29. Tamura K, Kanaoka Y, Jinno S, Nagata A, Ogiso Y, Shimizu K et al. (1993). Cyclin G: a new mammalian cyclin with homology to fission yeast Cig1. Oncogene 8: 2113-2118. (Pubitemid 23226944)
30. van Leuken R, Clijsters L, Wolthuis R. (2008). To cell cycle, swing the APC/C. Biochim biophys acta 1786: 49-59.
31. Weaver BA, Cleveland DW. (2005). Decoding the links between mitosis, cancer, and chemotherapy: the mitotic checkpoint, adaptation, and cell death. Cancer Cell 8: 7-12. (Pubitemid 40991810)